Ibogaine treatment for Phoenix residents: the physician-prescribed pathway through Brazil

Ibogaine is a Schedule I controlled substance in the United States. No clinic, hospital, or physician in Arizona can legally prescribe or administer it. That policy gap is not closing soon — even as Arizona has become the second state after Texas to fund ibogaine clinical research.

In June 2025, Arizona enacted House Bill 2871, appropriating $5 million in fiscal year 2026 for certified clinical research on ibogaine for neurological diseases including traumatic brain injury and PTSD. The Arizona Biomedical Research Centre opened grant applications in October 2025, with proposals required to originate from Arizona institutions with neurosurgery programs. That legislation matters. It does not help someone in active addiction today.

No Arizona resident can legally receive ibogaine treatment inside the United States as of June 2026. The April 2026 Executive Order on ibogaine research — with a specific focus on veterans — matters in Phoenix, home to Luke Air Force Base and a substantial military community. It does not create treatment access today.

Maricopa County's overdose trajectory makes the stakes visible. Fatal overdoses peaked at 1,666 in 2021 before falling to 1,500 in 2024. Fentanyl and methamphetamine co-use drives the fourth wave across the Valley — counterfeit pills moving along the I-10 corridor, polysubstance deaths where stimulants and synthetic opioids combine. Phoenix's naloxone distribution program has distributed nearly 30,000 kits since August 2023, contributing to declining fatal opioid overdoses in 2024. For Phoenix families who have exhausted local options, the physician-prescribed pathway runs through Brazil.

If your loved one is in active addiction, you have probably heard a lot of clinical language that did not translate into results. Ibogaine is worth understanding differently, because it works differently.

Ibogaine is a naturally occurring compound derived from the root bark of the iboga plant. It acts on multiple receptor systems simultaneously, including opioid receptors, NMDA receptors, and serotonin pathways. The result, for many patients, is a dramatic reduction in acute opioid withdrawal symptoms and a reset of the neurological patterns that drive compulsive use. The full receptor-level mechanism is covered in detail on our ibogaine overview.

What makes ibogaine different from medication-assisted treatment goes beyond pharmacology. It is the window that opens after. In the weeks following a session, the brain enters a period of elevated neuroplasticity, sometimes called the Window of Wonder, that typically lasts 2 to 12 weeks. This is not a passive recovery period. It is the window that Nekawa's 15-day on-site integration and 45-day at-home coursework are specifically built around, because what a student does during that window shapes what the session becomes long-term.

Ibogaine is not appropriate for everyone. The peer-reviewed research is serious and growing, and so is the understanding of who is and is not a candidate. Cardiac history, current medications, and other health factors all matter. That is precisely why the physician-prescribed pathway requires a full medical workup before any session proceeds.

The ibogaine session at the heart of Nekawa's program is prescribed and administered by independent licensed Brazilian physicians, not by Nekawa. Understanding what that means in practice matters, because it is the difference between a supervised medical procedure and an unmonitored retreat experience.

Before the prescribing physicians clear a patient for ibogaine, the workup includes:

• EKG
• QT-interval check
• Comprehensive blood panel
• Liver function test
• Magnesium loading

The QT-interval check is the critical cardiac screen. Ibogaine affects cardiac conduction, and a prolonged QT interval is a contraindication. This is not a formality. It is the reason the medical workup exists.

During the session, an on-site physician is present throughout. The hospital's ICU-trained nursing team monitors continuous cardiac telemetry for a minimum of 24 hours post-dose. The session itself moves through distinct phases: the intense visionary phase lasts 6 to 12 hours, followed by roughly 12 hours of quieter mental processing, then 24 to 48 hours of physical recuperation.

Nekawa's role is not clinical. We build the preparation, the environment, and the integration structure around the medical team's work. The full program structure is:

• 10 days of preparation and on-site medical onboarding before the session
• The ibogaine session, administered by the medical team in a hospital setting with continuous cardiac telemetry
• 15 days of structured integration on the property
• 45 days of at-home integration coursework after returning home

Longer on-site programs of up to 90 days are available for students who want deeper transformation work. The 28-day structure is the foundation; the extended program builds on it.

See our cardiac safety overview for the full QT-interval, EKG, and screening protocol the prescribing physicians follow.

Mexico and Costa Rica have become common destinations for ibogaine, and some of the programs there are run by serious people. But the regulatory framework is not the same, and that difference matters when you are talking about a compound that requires continuous cardiac monitoring.

In Brazil, ibogaine is approved for medical use under ANVISA, Brazil's federal health agency, the equivalent of the FDA. Treatment is prescribed by licensed physicians and delivered within hospital infrastructure that includes emergency response capability. This is not a private villa. It is not a retreat center operating in a gray area. The current US and global legal status of ibogaine makes clear why the structure of the Brazilian system is distinct.

Nekawa is a wellness education academy, structured around the hospital infrastructure that physician-administered ibogaine treatment requires. We do not run the medical protocol. The prescribing physicians do. What we provide is the preparation curriculum, the environment, the integration coursework, and the program structure that gives the medical session its full context.

The distinction matters for Phoenix students specifically. Arizona passed HB 2871 precisely because the evidence base is credible — and the state's fentanyl-driven toll across Maricopa County is part of why that policy conversation exists. The Americans for Ibogaine state legislation tracker lists Arizona among the states that have enacted ibogaine research legislation. That credibility is built on the kind of physician-prescribed, hospital-administered framework Brazil has operated under for years.

Phoenix Sky Harbor (PHX) connects to São Paulo–Guarulhos (GRU) or Rio de Janeiro–Galeão (GIG) via one-stop service through Dallas, Houston, or Los Angeles. Total travel time typically runs 12 to 16 hours door to door, depending on connection length.

From either GRU or GIG, it is a 4-hour drive along the BR-101 coastal highway to Paraty, on Brazil's Costa Verde coast. We arrange private ground transport from the airport, so students arrive directly without navigating Brazilian transit or making connections.

What you arrive to is not a medical facility. Our location sits in the Atlantic rainforest, the Mata Atlântica, at the edge of the sea. Old-growth jungle. Waterfalls. A protected lagoon. A bay scattered with more than 300 forested islands. The colonial port town of Paraty is just outside. The environment is part of the program. The preparation and integration work we walk students through is designed to use the setting intentionally.

As of January 1, 2026, US travelers need an approved Brazilian eVisa to enter Brazil. Apply online at brazil.vfsevisa.com.

• Cost: US$80.90
• Processing time: about 72 hours
• Validity: 10 years, multiple entries of up to 90 days per stay
• Passport: US passport with at least 6 months of remaining validity

Our intake team walks every student through this during onboarding.

Arizona is doing something few states have done. Governor Katie Hobbs signed the FY 2026 budget including HB 2871's $5 million ibogaine research appropriation — making Arizona the second state after Texas to commit state dollars to ibogaine clinical trials.

Americans for Ibogaine helped shape the national conversation alongside advocates including former Senator Kyrsten Sinema and Representative Justin Wilmeth (R-Phoenix). The law directs the Arizona Department of Health Services to award grants for certified clinical research on ibogaine for neurological diseases — primarily traumatic brain injury and PTSD in the enacted language. Grant recipients must be Arizona-based institutions with neurosurgery programs and proven neurological research history.

This is meaningful — Arizona joins Texas, Oklahoma, and Colorado among states actively building ibogaine research infrastructure. But clinical trials are not treatment access. A Phoenix resident in active addiction in June 2026 cannot receive ibogaine in Arizona, cannot enroll in a trial as a treatment pathway yet, and has no domestic medical provider to turn to for it.

At the federal level, the April 2026 Executive Order directed coordinated ibogaine research with a focus on veterans — relevant in a state with Luke Air Force Base and a substantial military community. It does not create treatment access today. Arizona recorded 2,992 provisional drug overdose deaths in 2024 per CDC NCHS data. For now, the physician-prescribed pathway runs through Brazil.

The ibogaine session is not the end of the program. It is closer to the beginning of the part that requires the most work.

The 45 days of at-home integration coursework that follow the on-site program are structured around the Window of Wonder, the 2 to 12 weeks of elevated neuroplasticity that follow the session. This is when the brain is most receptive to new patterns, and it is when the coursework is designed to be used. Students returning to Phoenix — to a condo in Biltmore, a house in Ahwatukee, or an apartment in Roosevelt Row — return to the same environment where the patterns formed. The at-home coursework is built with that reality in mind, including the social networks, economic stressors, and triggers that make recovery in this city its own challenge.

Phoenix's expanded naloxone distribution and public overdose dashboard reflect real public health progress. Integration is the complement on the other side of a medical session: structured reflection, specific practices, and ongoing engagement with the material from the preparation phase. Our team remains in contact with students through this period. The work continues.

For students with opioid dependence specifically, the opioid program page covers how the full curriculum is structured for that context. Students navigating burnout, depression, or anxiety alongside addiction may find the burnout and mental health program relevant as well.

The first step is a discovery call. This is a candidacy and program-fit conversation, not a sales call. We are looking at whether Nekawa's program is genuinely right for you or your loved one, and whether you are ready to do what the program requires.

On the call, we cover the program structure, the preparation curriculum, what the on-site experience involves, and what the at-home integration period looks like. We also talk honestly about who the program is not right for. Clinical screening is conducted separately by the prescribing physicians. What we assess is program fit, commitment, and readiness.

If the program is a fit, we move to intake, onboarding, and scheduling. Our intake team handles visa guidance, ground transport coordination, and preparation coursework. You do not navigate this alone.

To start, visit Book a discovery call. If you are a Phoenix family member trying to understand whether this is the right path, the discovery call is the right place to begin.